The U.S. antifungal drugs market, valued at USD 5.98 billion in 2024, is projected to experience steady growth over the next decade. According to the latest market insights, the market is expected to reach USD 7.96 billion by 2034, expanding at a CAGR of 2.9% from 2025 to 2034. The growth is fueled by the increasing burden of systemic fungal infections, rising use...